Literature DB >> 26592557

Characterization of iron metabolism and erythropoiesis in erythrocyte membrane defects and thalassemia traits.

Lucie Sulovska1, Dusan Holub2, Zuzana Zidova3, Martina Divoka4, Marian Hajduch2, Vladimir Mihal1, Jana Vrbkova2, Monika Horvathova3, Dagmar Pospisilova1.   

Abstract

BACKGROUND AND AIMS: Erythropoiesis is closely related to iron metabolism in a balanced homeostasis. Analyses of diverse erythroid and iron metabolism disorders have shown that disrupted erythropoiesis negatively affects iron homeostasis and vice versa. The aim of this study was to characterize the relationship between erythropoietic activity and iron homeostasis in pediatric patients with erythrocyte membrane defects and thalassemia traits.
METHODS: Selected markers of erythropoietic activity (erythropoietin, soluble transferrin receptor - sTfR and growth differentiation factor 15) and iron status parameters (serum iron, ferritin and hepcidin) were evaluated in pediatric patients with erythrocyte membrane defects and thalassemia traits.
RESULTS: The patients with erythrocyte membrane defects and thalassemia traits had altered iron homeostasis due to disturbed erythropoiesis. In comparison with healthy controls, they had a normal to low hepcidin/ferritin ratio and concomitantly elevated sTfR.
CONCLUSION: The findings suggest that pediatric patients with erythrocyte membrane defects and thalassemia traits are more susceptible to iron overload than the general population and that the (hepcidin/ferritin)/sTfR ratio can be used to monitor any worsening of the disease.

Entities:  

Keywords:  erythrocyte membrane defects; erythropoietic activity; hepcidin; thalassemia trait

Mesh:

Substances:

Year:  2015        PMID: 26592557     DOI: 10.5507/bp.2015.054

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  1 in total

1.  Abnormal concentration of porphyrins in serum from COVID-19 patients.

Authors:  Itxaso San Juan; Chiara Bruzzone; Maider Bizkarguenaga; Ganeko Bernardo-Seisdedos; Ana Laín; Rubén Gil-Redondo; Tammo Diercks; Jon Gil-Martínez; Pedro Urquiza; Eunate Arana; Marisa Seco; Aitor García de Vicuña; Nieves Embade; José M Mato; Oscar Millet
Journal:  Br J Haematol       Date:  2020-08-29       Impact factor: 6.998

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.